Pediatric Diabetes

Children with diabetes from four Latin American countries with access to telemedicine had more medical visits and recorded HbA1c compared with those without access to telemedicine, according to study data.

Non-Hispanic Black children are less likely to start continuous glucose monitoring within 1 year of diabetes diagnosis compared with non-Hispanic white children, according to study data.

The percentage of youths with type 1 diabetes spending at least 70% time in range more than doubled after 3 months of using a hybrid closed-loop insulin delivery system, according to a study published in Diabetes Technology & Therapeutics.

Children and teens with type 1 diabetes and two or more comorbidities or a mental health condition have a worse health-related quality of life compared with those with no comorbidities, according to a study published in Diabetic Medicine.

Pediatric diabetes research is an area that hits close to home for Kristen Nadeau, MD, MS, professor of pediatric endocrinology at the University of Colorado Anschutz Medical Campus.

The COVID-19 pandemic highlighted some of the disparities children face in diabetes prevention and care, according to a presenter at the American Diabetes Association Scientific Sessions.

Children with type 2 diabetes with a parental — particularly, maternal — history of diabetes have elevated risks for adverse outcomes and early onset of complications, according to a speaker.

Children who have at least one parent with obesity can improve insulin sensitivity and insulin secretion with more physical activity and less sedentary behavior, according to a speaker.

Daily oral insulin therapy may improve glucose and C-peptide measurements for a subset of children at high risk for type 1 diabetes, according to new TrialNet data presented at the American Diabetes Association Scientific Sessions.

Youths diagnosed with type 2 diabetes at an older age and those who adhere to metformin therapy are more likely to progress to therapy with insulin or a non-insulin antihyperglycemic agent, according to a speaker.